Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-07-08 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
关于召开2024年第三次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2024 third extraordinary general meeting of shareholders, detailing the meeting date, voting methods, agenda items, and procedural instructions. It does not contain financial statements, audit results, or detailed financial data. The document is relatively short (3100 characters) and serves as an announcement for the meeting rather than the meeting minutes or voting results. Therefore, it fits the category of a shareholder meeting notice, which aligns with the AGM Information (AGM-R) category, as it provides materials related to the Annual or Extraordinary General Meeting.
2024-07-08 Chinese
董事、监事和高级管理人员持股及其变动管理办法（2024年7月修订）
Governance Information Classification · 95% confidence The document is titled as a management method regarding the shareholding and changes of shares held by directors, supervisors, and senior management personnel of the company. It contains detailed rules and regulations about shareholding restrictions, trading prohibitions, reporting obligations, and compliance with relevant laws and stock exchange regulations. There is no indication that this is a financial report, earnings release, or any form of meeting presentation or voting result. Instead, it is a governance-related document outlining internal rules and compliance for management shareholding. Therefore, it fits best under Governance Information (CGR). The document length is about 5,047 characters, which is sufficient for a substantive governance policy document rather than a brief announcement or certification.
2024-07-08 Chinese
关于变更监事暨提名监事候选人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of a company supervisor and the nomination of a new supervisor candidate. It includes details about the resignation, the legal basis for the change, and the nominee's qualifications. There are no financial statements, earnings data, or regulatory certifications. The content focuses on changes in the company's supervisory board, which falls under management or board information. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and does not indicate it is a report or announcement of a report publication, so it is not RPA or RNS.
2024-07-08 Chinese
关于拟变更公司名称、经营范围并修订《公司章程》的公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from a company's board regarding proposed changes to the company name, business scope, and amendments to the company's articles of association (company charter). It includes detailed explanations of the reasons for the changes, the specific amendments to the articles, and the procedural steps including submission to a shareholders' meeting for approval. There are no financial statements, audit opinions, or earnings data presented. The document is not a full annual or interim report, nor is it a transcript or presentation. It is a regulatory announcement about corporate governance changes and company structural updates. This fits best under the category of Board/Management Information (MANG), as it concerns changes in company governance documents and corporate structure, but not changes in board members per se. The document is lengthy and detailed, not a brief notice or a report publication announcement. Therefore, the classification is MANG with high confidence.
2024-07-08 Chinese
德恒上海律师事务所关于天域生态环境股份有限公司2024年第二次临时股东大会的法律意见书
Regulatory Filings
2024-07-03 Chinese
2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions from an extraordinary shareholders meeting held on July 3, 2024. It details the meeting attendance, voting results, and legal opinions confirming the validity of the meeting and resolutions. The document does not contain financial statements or detailed financial analysis but focuses on the meeting outcomes and voting results. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1598 characters), and it is not a report publication announcement or a regulatory filing. Therefore, the appropriate classification is DVA with high confidence.
2024-07-03 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.